As of 2025-03-15, the Relative Valuation of Stoke Therapeutics Inc (STOK) is (75.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.11 USD, the upside of Stoke Therapeutics Inc based on Relative Valuation is -1025.5%.
The range of the Relative Valuation is (62.55) - (94.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 47.6x | 41.1x |
| Forward P/E multiples | 26.9x - 48.2x | 34.3x |
| Fair Price | (62.55) - (94.73) | (75.06) |
| Upside | -871.3% - -1268.0% | -1025.5% |
| Date | P/E |
| 2025-03-07 | -4.08 |
| 2025-03-06 | -4.09 |
| 2025-03-05 | -4.10 |
| 2025-03-04 | -3.81 |
| 2025-03-03 | -3.72 |
| 2025-02-28 | -3.94 |
| 2025-02-27 | -4.01 |
| 2025-02-26 | -4.15 |
| 2025-02-25 | -4.14 |
| 2025-02-24 | -4.27 |
| 2025-02-21 | -4.18 |
| 2025-02-20 | -4.39 |
| 2025-02-19 | -4.67 |
| 2025-02-18 | -4.88 |
| 2025-02-14 | -5.36 |
| 2025-02-13 | -5.34 |
| 2025-02-12 | -5.15 |
| 2025-02-11 | -5.18 |
| 2025-02-10 | -5.16 |
| 2025-02-07 | -5.70 |
| 2025-02-06 | -6.40 |
| 2025-02-05 | -6.38 |
| 2025-02-04 | -6.33 |
| 2025-02-03 | -5.79 |
| 2025-01-31 | -5.77 |
| 2025-01-30 | -5.52 |
| 2025-01-29 | -5.28 |
| 2025-01-28 | -4.93 |
| 2025-01-27 | -5.31 |
| 2025-01-24 | -5.33 |
| 2025-01-23 | -5.32 |
| 2025-01-22 | -5.03 |
| 2025-01-21 | -4.92 |
| 2025-01-17 | -4.70 |
| 2025-01-16 | -4.75 |
| 2025-01-15 | -4.77 |
| 2025-01-14 | -4.36 |
| 2025-01-13 | -4.48 |
| 2025-01-10 | -4.52 |
| 2025-01-08 | -4.50 |
| 2025-01-07 | -4.68 |
| 2025-01-06 | -5.54 |
| 2025-01-03 | -5.77 |
| 2025-01-02 | -5.66 |
| 2024-12-31 | -5.54 |
| 2024-12-30 | -5.42 |
| 2024-12-27 | -5.56 |
| 2024-12-26 | -5.65 |
| 2024-12-24 | -5.69 |
| 2024-12-23 | -5.83 |